Financial results - BIOMEDICA-NOVA SRL

Financial Summary - Biomedica-Nova Srl
Unique identification code: 22094111
Registration number: J2007001283243
Nace: 8691
Sales - Ron
732.177
Net Profit - Ron
31.927
Employees
18
Open Account
Company Biomedica-Nova Srl with Fiscal Code 22094111 recorded a turnover of 2024 of 732.177, with a net profit of 31.927 and having an average number of employees of 18. The company operates in the field of Servicii de diagnostic imagistic și activități ale laboratoarelor medicale having the NACE code 8691.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Biomedica-Nova Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 277.501 327.925 471.906 562.848 596.177 572.527 631.944 665.151 689.890 732.177
Total Income - EUR 306.044 366.140 509.089 593.492 620.727 589.408 644.593 698.137 695.810 738.698
Total Expenses - EUR 253.558 332.724 394.389 479.644 520.881 518.258 635.867 689.876 720.315 700.777
Gross Profit/Loss - EUR 52.485 33.416 114.700 113.848 99.846 71.150 8.725 8.262 -24.504 37.921
Net Profit/Loss - EUR 47.743 29.681 109.423 108.061 93.986 66.571 3.540 2.031 -32.560 31.927
Employees 13 17 18 19 21 20 22 23 22 18
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 6.7%, from 689.890 euro in the year 2023, to 732.177 euro in 2024. The Net Profit increased by 31.927 euro, from 0 euro in 2023, to 31.927 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Biomedica-Nova Srl

Rating financiar

Financial Rating -
BIOMEDICA-NOVA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Biomedica-Nova Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Biomedica-Nova Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Biomedica-Nova Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Biomedica-Nova Srl - CUI 22094111

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 223.617 259.054 234.594 290.580 365.968 520.139 586.786 637.807 657.682 625.463
Current Assets 62.745 37.794 127.377 193.665 196.391 119.932 106.402 73.418 81.250 98.416
Inventories 2.821 6.910 5.195 16.470 40.655 70.487 59.022 22.646 13.705 13.953
Receivables 25.666 26.576 48.020 40.391 46.820 44.713 41.070 47.882 53.691 10.152
Cash 34.259 4.309 74.161 136.803 108.916 4.732 6.310 2.890 13.855 74.311
Shareholders Funds 182.485 215.930 310.753 442.134 519.128 575.858 566.628 567.458 533.177 562.124
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 49.828 86.561 36.143 42.110 43.230 70.628 138.113 149.324 178.161 145.563
Income in Advance 54.048 34.415 15.074 0 0 0 0 0 34.370 31.227
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8691 - 8691"
CAEN Financial Year 8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 98.416 euro in 2024 which includes Inventories of 13.953 euro, Receivables of 10.152 euro and cash availability of 74.311 euro.
The company's Equity was valued at 562.124 euro, while total Liabilities amounted to 145.563 euro. Equity increased by 31.927 euro, from 533.177 euro in 2023, to 562.124 in 2024. The Debt Ratio was 19.7% in the year 2024.

Risk Reports Prices

Reviews - Biomedica-Nova Srl

Comments - Biomedica-Nova Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.